Effect of a Light Stimulated Footsteps Pathway on Gait in Spastic Children

Effect of a Light Stimulated Footsteps Pathway on Kinematics of Gait in Spastic Diplegic Children

PURPOSE: The purpose of this study will be investigation of the effect oflight stimulated footsteps pathway on kinematics of gait in spastic diplegic children BACKGROUND: The goal of most therapy procedures for children with spastic cerebral palsy is to increase their walking abilities. Locomotor training usinglight stimulated footsteps pathwayhas been recommended for the rehabilitation of children with cerebral palsy in an effort to improve walking independence and gait speed.

HYPOTHESES: Walking on light stimulated footsteps pathway may not affect kinematics of gait in spastic diplegic children RESEARCH QUESTION: Does walking on light stimulated footsteps pathway have any effect onkinematics of gait in spastic diplegic children?

Study Overview

• Status: Active, not recruiting
• Conditions: Spastic Diplegia
• Intervention / Treatment: Other: therapeutic exercise; Other: gait training on light stimulated footsteps pathway

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Giza, Egypt
    • Cairo University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Age will range between5 and 8 years old.
• They had Grade 1 and 1+ hypertonia according to Modified Ashworth Scale (Bohannon and Smith, 1987)
• Motor Classification System, they were at level I and II (GMFCS)
• They will capable of following commands and comprehend them.
• They will exhibit defective gait kinematics, which can be determined through gait kinematics evaluation.
• All patients who will be enrolled to the study will have their informed consent.

Exclusion Criteria:

• Epilepsy history.
• Taking any anti spastic drugs.
• Both lower limbs had permanent deformity.
• Surgical intervention history.
• Have visual or auditory defects.
• Chest infections or unstable cardiac status.
• Infective skin conditions.
• Markedly high or low blood pressure.
• Individuals with cardiopulmonary conditions.
• Individuals with any pelvic disease.
• Individuals undergoing radiation therapy or chemotherapy.
• Hepatic or pancreatic diseases.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Control Group (A); This group of fifteen children received a regular traditional therapeutic exercise program three times per week for three month based on the Pragmatic approach .	Other: therapeutic exercise; Balance training from different positions. Weight shifting exercises by facilitation of single limb support while standing. Ascending and descending stairs. Gait training between parallel bars applied three times per week for three month
Experimental: Study Group (B); The fifteen children in this group got the same therapeutic exercise program as the control group, as well as 30 minutes of gait training on light stimulated footsteps pathway three times per week for three month.	Other: therapeutic exercise; Balance training from different positions. Weight shifting exercises by facilitation of single limb support while standing. Ascending and descending stairs. Gait training between parallel bars applied three times per week for three month; Other: gait training on light stimulated footsteps pathway; same routine program as the control group as well as 30 minutes of gait training on light stimulated footsteps pathway: Walk on the light stimulated footsteps (Forward steps); Walk on the light stimulated footsteps (backward steps); Tandem gait over light yellow line applied three times per week for three month

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
step length	kinovea software used to evaluate step length The unit of measurement for Step Length is centimeter (cm)	At baseline and re assessed following 3 months
step width	kinovea software used to evaluate step width The unit of measurement for Step width is centimeter (cm)	At baseline and re assessed following 3 months
spasticity	The Modified Ashworth Scale (MAS) used for evaluation MAS assigns a grade of spasticity from a 0-4 ordinal scale. The grade is assigned by moving a joint/muscle through a high velocity quick stretch.	At baseline and re assessed following 3 months
gross motor function	The Gross Motor Function Measure (GMFM) is a standardized tool used to assess changes in gross motor function in children, particularly those with cerebral palsy. The GMFM uses a four-point ordinal scale for scoring each item, where: 0: Does not initiate; Initiates (but does not complete); Partially completes; Completes the task fully Scores can be summed to calculate raw and percent scores for each dimension and a total GMFM score.	At baseline and re assessed following 3 months

Collaborators and Investigators

• Sponsor: Amira saad mohamed

Study record dates

Study Major Dates

• Study Start (Actual): September 20, 2025
• Primary Completion (Estimated): April 27, 2026
• Study Completion (Estimated): May 20, 2026

Study Registration Dates

• First Submitted: December 4, 2025
• First Submitted That Met QC Criteria: December 4, 2025
• First Posted (Actual): December 17, 2025

Study Record Updates

• Last Update Posted (Actual): April 6, 2026
• Last Update Submitted That Met QC Criteria: April 1, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Brain Damage, Chronic; Cerebral Palsy; Therapeutics; Physical Therapy Modalities; Patient Care; Rehabilitation; Aftercare; Continuity of Patient Care; Exercise Therapy
• Other Study ID Numbers: 012/006097

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No